___

• 1. Forsythe, E. and P.L. Beales, Bardet–Biedl syndrome. European journal of human genetics, 2013. 21(1): p. 8-13.
• 2. Suspitsin, E.N. and E.N. Imyanitov, Bardet-biedl syndrome. Molecular syndromology, 2016. 7(2): p. 62-71.
• 3. Ansley, S.J., et al., Basal body dysfunction is a likely cause of pleiotropic Bardet–Biedl syndrome. Nature, 2003. 425(6958): p. 628-633.
• 4. Waters, A.M. and P.L. Beales, Ciliopathies: an expanding disease spectrum. Pediatric nephrology, 2011. 26(7): p. 1039-1056.
• 5. Ramirez, N., et al., Orthopaedic manifestations of Bardet-Biedl syndrome. Journal of Pediatric Orthopaedics, 2004. 24(1): p. 92-96.
• 6. Stevens, C.A. and J.C. Ledbetter, Significance of bifid epiglottis. American Journal of Medical Genetics Part A, 2005. 134(4): p. 447-449.
• 7. Elbedour, K., et al., Cardiac abnormalities in the Bardet‐Biedl syndrome: Echocardiographic studies of 22 patients. American journal of medical genetics, 1994. 52(2): p. 164-169.
• 8. Mujahid, S., et al., The endocrine and metabolic characteristics of a large bardet-biedl syndrome clinic population. The Journal of Clinical Endocrinology & Metabolism, 2018. 103(5): p. 1834-1841.
• 9. Ono, Y., et al., Efficacy and safety of sugammadex in patients undergoing renal transplantation. JA clinical reports, 2018. 4(1): p. 1-4.
• 10. Collins, C.M., et al., Pediatric renal transplantation in Laurence-Moon-Biedl syndrome. Pediatric Nephrology, 1994. 8(2): p. 221-222